發(fā)布時(shí)間：2018-10-13 10:52

【摘要】：隨著國家醫(yī)療保險(xiǎn)制度改革,醫(yī)療體制改革,醫(yī)藥流通體制改革和藥品分類管理制度的實(shí)施,我國的醫(yī)藥生產(chǎn)、銷售、流通、消費(fèi)等均發(fā)生了巨大變化。對(duì)此企業(yè)迫切需要適用于處方藥運(yùn)作的營(yíng)銷理論和實(shí)用體系作指導(dǎo),需要一套完整的處方藥營(yíng)銷策略。本文站在歐立制藥集團(tuán)的角度,通過對(duì)處方藥醫(yī)院終端市場(chǎng)現(xiàn)狀、處方藥的營(yíng)銷渠道特點(diǎn)及公司狀況的分析,指出了處方藥營(yíng)銷渠道目前存在的誤區(qū)及不足,提出了歐立制藥處方藥營(yíng)銷策略的選擇。在處方藥營(yíng)銷策略類型及特征分析和國外處方藥新營(yíng)銷經(jīng)驗(yàn)借鑒的基礎(chǔ)上,提出歐立處方藥營(yíng)銷渠道的轉(zhuǎn)變方向。最后,本文制定了歐立制藥處方藥營(yíng)銷策略的實(shí)施措施,實(shí)施學(xué)術(shù)性推廣營(yíng)銷策略、針對(duì)醫(yī)院終端的營(yíng)銷策略、針對(duì)患者終端的營(yíng)銷策略。本文的研究結(jié)果希望能為歐立制藥集團(tuán)的健康發(fā)展提供了良好的借鑒和幫助。
[Abstract]:With the reform of the national medical insurance system, the reform of the medical system, the reform of the medicine circulation system and the implementation of the drug classification management system, great changes have taken place in the production, sale, circulation and consumption of medicine in China. Enterprises urgently need guidance of marketing theory and practical system applicable to the operation of prescription drugs and a complete set of marketing strategies for prescription drugs. Based on the analysis of the status quo of the terminal market of prescription drug hospitals, the characteristics of the marketing channels and the company status of prescription drugs, this paper points out the misunderstandings and shortcomings in the marketing channels of prescription drugs from the point of view of Ole Pharmaceutical Group. The selection of marketing strategy for prescription drugs of Ole Pharmaceutical is put forward. On the basis of the analysis of the types and characteristics of prescription drug marketing strategy and the experience of new prescription drug marketing abroad, this paper puts forward the changing direction of Oli prescription drug marketing channel. Finally, this paper formulates the implementation measures of the Ole pharmaceutical prescription drug marketing strategy, carries out the academic promotion marketing strategy, the marketing strategy for the hospital terminal, the marketing strategy for the patient terminal. The research results of this paper hope to provide good reference and help for the healthy development of Euler Pharmaceutical Group.
【學(xué)位授予單位】：廣東財(cái)經(jīng)大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2015
【分類號(hào)】：F274;F426.72

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 田恒運(yùn);郭志剛;陳永建;;處方藥營(yíng)銷模式的探討[J];廣東化工;2014年20期

2 趙振基;;處方藥營(yíng)銷的桐君閣原則[J];中國藥店;2014年13期

3 蒙永亨;汪水蘭;;醫(yī)藥企業(yè)處方藥營(yíng)銷策略研究[J];桂林航天工業(yè)學(xué)院學(xué)報(bào);2014年01期

4 王曉君;;淺談我國非處方藥的市場(chǎng)營(yíng)銷策略[J];山西財(cái)政稅務(wù)�？茖W(xué)校學(xué)報(bào);2014年01期

5 韓磊;馮國忠;;非處方藥營(yíng)銷渠道現(xiàn)狀以及策略分析[J];現(xiàn)代商貿(mào)工業(yè);2012年24期

6 蘇濤;常峰;邵蓉;;對(duì)美國藥品集中采購組織的解析[J];上海醫(yī)藥;2011年06期

7 郭瑩;邢花;劉建巍;;我國處方藥應(yīng)嘗試直接面對(duì)消費(fèi)者廣告營(yíng)銷[J];中國藥業(yè);2011年10期

8 宿凌;張靈幸;黃文龍;;知名品牌的非處方藥與處方藥市場(chǎng)營(yíng)銷策略組合的比較研究[J];中國藥房;2010年45期

9 李亦兵;;處方藥的隱性品牌營(yíng)銷與傳播對(duì)策研究[J];西南農(nóng)業(yè)大學(xué)學(xué)報(bào)(社會(huì)科學(xué)版);2009年06期

10 啟言;;處方藥營(yíng)銷五大趨勢(shì)[J];市場(chǎng)觀察;2009年12期

，

本文編號(hào)：2268349